Good volume and a nice amount of buys today. Then comes fifth patient dosing. Not much left in the area of news left to keep this stock down.
I seriously believe the fierce biotech author is misreading the last release by Benitec. They provided nothing new, and I don't believe they see that they are insinuating a viral load effect, when in fact, that has not been demonstrated yet.
News 
Market Data 
Discover 
